Expert Insights
Our customers
love what we do
I can go on Google and look up the last ten papers written on a robot device. But what Lumere does is digest a lot of that information and grade the evidence. They differentiate between a randomized trial with a government sponsor versus a company-sponsored, non-randomized trial that may have significant bias.
Dr. Christopher White
Medical Director of Value-Based Care; System Chair, Cardiovascular Diseases, Ochsner Health SystemSelect Clients
Over 65 health systems in more than 40 states rely on Lumere’s solutions and services, including:
Upcoming Events
How a Value Analysis Evolution Led to a Performance-Based Contract Revolution
- Jun 08, 2021
Does value analysis have a role to play in the fiscal success of a health system? It does at Spectrum Health! Join Kristen Sinke and Amy Bertotti as they share obstacles and learnings from Spectrum Health’s 2-year journey to create a more clinically integrated supply chain. These value analysis professionals will discuss how they developed a more advanced and proactive system-level value analysis program.
Latest News
PE Firm Warburg Pincus Makes Minority Investment in GHX, Thoma Bravo Exits
- Jun 03, 2021
- /
- HIT Consultant
GHX, a healthcare supply chain leader announced it has entered into a definitive agreement to receive a strategic investment from private equity firm Warburg Pincus.
Top of the Morning | Private Equity Deals
- Jun 03, 2021
- /
- AXIOS
Lux Capital is one of the original "frontier" tech venture firms, investing in startups that leverage colliding scientific advancements to create new categories. And now it's got a lot more money in the bank, so it seemed like a good time to...